Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 2
1994 5
1995 4
1996 3
1997 4
1998 6
1999 11
2000 14
2001 8
2002 11
2003 14
2004 7
2005 19
2006 11
2007 16
2008 12
2009 15
2010 10
2011 9
2012 19
2013 17
2014 6
2015 11
2016 18
2017 19
2018 8
2019 7
2020 10
2021 8
2022 15
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

287 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacology of Adenosine Receptors: The State of the Art.
Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Borea PA, et al. Among authors: varani k. Physiol Rev. 2018 Jul 1;98(3):1591-1625. doi: 10.1152/physrev.00049.2017. Physiol Rev. 2018. PMID: 29848236 Free article. Review.
Adenosine and Inflammation: Here, There and Everywhere.
Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Pasquini S, et al. Among authors: varani k. Int J Mol Sci. 2021 Jul 19;22(14):7685. doi: 10.3390/ijms22147685. Int J Mol Sci. 2021. PMID: 34299305 Free PMC article. Review.
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases.
Merighi S, Borea PA, Varani K, Vincenzi F, Jacobson KA, Gessi S. Merighi S, et al. Among authors: varani k. Curr Med Chem. 2022;29(24):4138-4151. doi: 10.2174/0929867328666211129122550. Curr Med Chem. 2022. PMID: 34844537 Free PMC article. Review.
Anxiolytic properties of A1 adenosine receptor PAMs.
Vincenzi F, Borea PA, Varani K. Vincenzi F, et al. Among authors: varani k. Oncotarget. 2017 Jan 31;8(5):7216-7217. doi: 10.18632/oncotarget.13802. Oncotarget. 2017. PMID: 28055953 Free PMC article. No abstract available.
Pathological overproduction: the bad side of adenosine.
Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Borea PA, et al. Among authors: varani k. Br J Pharmacol. 2017 Jul;174(13):1945-1960. doi: 10.1111/bph.13763. Epub 2017 Mar 31. Br J Pharmacol. 2017. PMID: 28252203 Free PMC article. Review.
Adenosine receptors in health and disease.
Gessi S, Merighi S, Varani K, Borea PA. Gessi S, et al. Among authors: varani k. Adv Pharmacol. 2011;61:41-75. doi: 10.1016/B978-0-12-385526-8.00002-3. Adv Pharmacol. 2011. PMID: 21586355 Review.
The A3 adenosine receptor: history and perspectives.
Borea PA, Varani K, Vincenzi F, Baraldi PG, Tabrizi MA, Merighi S, Gessi S. Borea PA, et al. Among authors: varani k. Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540. Pharmacol Rev. 2015. PMID: 25387804 Review.
Current status of A1 adenosine receptor allosteric enhancers.
Romagnoli R, Baraldi PG, Moorman AR, Borea PA, Varani K. Romagnoli R, et al. Among authors: varani k. Future Med Chem. 2015;7(10):1247-59. doi: 10.4155/fmc.15.65. Future Med Chem. 2015. PMID: 26144263 Review.
287 results